Cargando…

Extension of the therapeutic spectrum in castration-resistant prostate cancer: Osteoclast inhibition with denosumab

Detalles Bibliográficos
Autores principales: Wolff, Johannes M., Schmid, Hans-Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708202/
https://www.ncbi.nlm.nih.gov/pubmed/26816697
http://dx.doi.org/10.3978/j.issn.2223-4683.2012.05.03
_version_ 1782409420084346880
author Wolff, Johannes M.
Schmid, Hans-Peter
author_facet Wolff, Johannes M.
Schmid, Hans-Peter
author_sort Wolff, Johannes M.
collection PubMed
description
format Online
Article
Text
id pubmed-4708202
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-47082022016-01-26 Extension of the therapeutic spectrum in castration-resistant prostate cancer: Osteoclast inhibition with denosumab Wolff, Johannes M. Schmid, Hans-Peter Transl Androl Urol Research Highlight AME Publishing Company 2012-06 /pmc/articles/PMC4708202/ /pubmed/26816697 http://dx.doi.org/10.3978/j.issn.2223-4683.2012.05.03 Text en 2012 Translational Andrology and Urology. All rights reserved.
spellingShingle Research Highlight
Wolff, Johannes M.
Schmid, Hans-Peter
Extension of the therapeutic spectrum in castration-resistant prostate cancer: Osteoclast inhibition with denosumab
title Extension of the therapeutic spectrum in castration-resistant prostate cancer: Osteoclast inhibition with denosumab
title_full Extension of the therapeutic spectrum in castration-resistant prostate cancer: Osteoclast inhibition with denosumab
title_fullStr Extension of the therapeutic spectrum in castration-resistant prostate cancer: Osteoclast inhibition with denosumab
title_full_unstemmed Extension of the therapeutic spectrum in castration-resistant prostate cancer: Osteoclast inhibition with denosumab
title_short Extension of the therapeutic spectrum in castration-resistant prostate cancer: Osteoclast inhibition with denosumab
title_sort extension of the therapeutic spectrum in castration-resistant prostate cancer: osteoclast inhibition with denosumab
topic Research Highlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708202/
https://www.ncbi.nlm.nih.gov/pubmed/26816697
http://dx.doi.org/10.3978/j.issn.2223-4683.2012.05.03
work_keys_str_mv AT wolffjohannesm extensionofthetherapeuticspectrumincastrationresistantprostatecancerosteoclastinhibitionwithdenosumab
AT schmidhanspeter extensionofthetherapeuticspectrumincastrationresistantprostatecancerosteoclastinhibitionwithdenosumab